
NSL-3RT
Triple agonist research peptide (GLP-1 / GIP / glucagon) studied for metabolic and body-composition endpoints.

Mitochondrial-derived research peptide studied for metabolic and cellular energy endpoints.
Multi-vial deal: Buy 2, save 2% · 3, save 3% · 4, save 5% · 5+, save 10% on the same item, on top of the sale price (applied automatically in your cart).
A lot-specific report for 40mg is not published yet. Request documentation.
MOTS-c is a mitochondrial-derived peptide encoded within the mitochondrial genome, studied for its involvement in cellular energy metabolism and AMPK pathway activation in preclinical research models.
Laboratories investigate MOTS-c in the context of metabolic stress response, mitochondrial-nuclear communication, and exercise-adaptation signaling in cell-culture and animal-model systems.
Each lot undergoes independent third-party verification prior to release, and documentation is available for buyers upon request.
| Form | Lyophilized powder |
|---|---|
| Quantity per vial | 40mg |
| Appearance | White lyophilized powder |
| SKU | NSL-MOTSC-40 |
Lots are submitted for independent third-party analysis. Methods vary by lot and are listed on each published COA; where no current COA is published, lot documentation is available on request.
No current COA is published for this product. Documentation is available on request via our contact page.
Learn more on our Testing & Quality page or browse the COA library.
MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial 12S rRNA gene, studied in cell and rodent models for AMPK-linked metabolic signaling. Human data are observational rather than interventional.
Read the MOTS-c research overviewFree U.S. shipping on orders over $200; otherwise a flat $9.99 shipping rate applies. All sales are final.See our full Shipping & Returns policy for details.
It is a peptide encoded within mitochondrial DNA, studied as a signaling molecule in metabolic research.
MOTS-c ships as a 40mg lyophilized vial.
Yes, on request for the specific lot shipped.

Triple agonist research peptide (GLP-1 / GIP / glucagon) studied for metabolic and body-composition endpoints.

Dual GIP/GLP-1 receptor agonist researched for glucose regulation and weight-related endpoints.
All products sold by North Summit Labs are intended strictly for in-vitro laboratory research and are not for human or animal consumption.